FG-4592 |
Subjects with anemia associated with chronic kidney disease without dialysis (phase III) |
Evaluate the efficacy for treatment of anemia correction and hemoglobin correction as well as their maintenance |
NCT01750190 (recruiting) |
AKB-6548 |
Subjects with end stage renal disease undergoing chronic hemodialysis (phase II) |
Evaluate the hemoglobin response (efficacy), safety, and tolerability |
NCT02260193 (activated, but not recruiting) |
GSK-1278863 |
Hemodialysis dependent subjects with anemia associated with chronic kidney diseases, chronically hyporesponsive to recombinant human EPO (phase II) |
Evaluate the safety and efficacy after switching from recombinant human EPO |
NCT02075463 (recruiting) |
BAY-85-3934 |
Subjects with anemia associated with chronic kidney disease on dialysis, in USA and Japan (phase II) |
Evaluate the efficacy and safety of oral BAY-85-3934 and active comparator in the long term treatment |
NCT02064426 (recruiting) |